No abstract available
MeSH terms
-
Adolescent
-
Adult
-
Age Factors
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Biomarkers, Tumor / blood
-
Bleomycin / administration & dosage
-
Bone Neoplasms / blood
-
Bone Neoplasms / drug therapy*
-
Bone Neoplasms / mortality
-
Bone Neoplasms / pathology
-
Bone Neoplasms / surgery
-
Chemotherapy, Adjuvant
-
Child
-
Child, Preschool
-
Cisplatin / administration & dosage
-
Combined Modality Therapy
-
Cyclophosphamide / administration & dosage
-
Dactinomycin / administration & dosage
-
Doxorubicin / administration & dosage
-
Female
-
Humans
-
Male
-
Methotrexate / administration & dosage
-
New York / epidemiology
-
Osteosarcoma / blood
-
Osteosarcoma / drug therapy*
-
Osteosarcoma / mortality
-
Osteosarcoma / pathology
-
Osteosarcoma / surgery
-
Prognosis
-
Proportional Hazards Models
-
Racial Groups
-
Retrospective Studies
-
Risk
-
Survival Rate
-
Treatment Outcome
Substances
-
Biomarkers, Tumor
-
Bleomycin
-
Dactinomycin
-
Doxorubicin
-
Cyclophosphamide
-
Cisplatin
-
Methotrexate